EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Improved lipid and glycemic profile and vitamin D levels after a dietary intervention with SSRD and low FODMAP in IBS patients: A randomized controlled trial

Bodil Roth, Mauro D'Amato, Bodil Ohlsson

Nutrition · 2026

DOI: 10.1016/j.nut.2025.112964 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrition, 2026. Verfasst von Bodil Roth und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Lund University, Malmö, Sweden; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden. Hauptthemen laut MEDLINE: Blood Glucose, Irritable Bowel Syndrome, Vitamin D, Diet, Carbohydrate-Restricted. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Irritable bowel syndrome (IBS) is the most common disorder of gut-brain interaction and associated with overweight. Low content of fermentable oligo-, di-, and monosaccharides and polyols (FODMAP) and a starch- and sucrose-reduced diet (SSRD) alleviate IBS symptoms, but restrictive diets may lead to malnutrition. The aim of the present clinical trial was to randomize IBS patients to either SSRD or low FODMAP and compare circulating metabolic and nutritional status over time. METHODS: Of 155 included patients, 77 received SSRD and 78 low FODMAP for 4 weeks, with a follow-up at 6 months. Study and Rome IV questionnaires, food diary, IBS-severity scoring system, and visual analog scale for IBS were completed, along with blood sampling and anthropometric measurements. Albumin, C-reactive peptide, glycosylated hemoglobin A1c (HbA1c) (mmol/mol), lipid profile (mmol/L), and micronutrients were analyzed in plasma/serum. RESULTS: Both diets improved gastrointestinal and extraintestinal symptoms. The weight reduction was most pronounced in SSRD (-1.6(-2.4 to [-0.4] kg vs. -0.8(-1.6 to [-0.1] kg; P = 0.006). Cholesterol (-0.1(-0.5 to 0.1), P = 0.007; -0.2(-0.4 to 0.1), P = 0.009), low-density lipoprotein (LDL) (-0.2(-0.4 to 0.1), P = 0.004; -0.1(-0.4 to 0.1), P = 0.017), and non-high-density lipoprotein (non-HDL) (-0.1(-0.4 to 0.1), P = 0.015; -0.1(-0.4 to 0.1), P = 0.008) decreased at week 4 and month 6 in the SSRD group, but only after 4 weeks in the low FODMAP group (-0.2(-0.5 to 0.2), P = 0.003; -0.1(-0.3 to 0.1), P = 0.036; and -0.2(-0.4 to 0.1), P = 0.002, respectively). At week 4, HbA1c decreased (0(-1.0 to 0), P = 0.010 and (0(-1.0 to 0), P = 0.009) and vitamin D increased (6(-3 to 16) nmol/L, P = 0.004 and 4(-5 to 14) nmol/L, P = 0.017) in both groups, with continued elevated vitamin D levels after SSRD. Folate increased and iron decreased in the SSRD group. Lower calcium and ferritin levels were found after low FODMAP. At 6 months, cobalamin was lower in both groups. CONCLUSIONS: SSRD and low FODMAP improve symptoms and the lipid, glycemic, and vitamin D profiles. The improved lipid and vitamin D profiles remained at follow-up in the SSRD group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseIrritable Bowel SyndromeVitamin DDiet, Carbohydrate-RestrictedLipidsHumansMaleFemaleAdultMiddle AgedGlycated HemoglobinPolymersFermentationNutritional StatusMonosaccharidesGlycemic IndexC-Reactive ProteinOligosaccharides

Stichwörter der Autor:innen

Dietary habitsHbA1cIrritable bowel syndromeLipid profileLow FODMAPStarch- and sucrose-reduced diet (SSRD, Randomized controlled trial (RCT)

Substanzen

Blood GlucoseVitamin DGlycated HemoglobinLipidsPolymerspolyolMonosaccharidesC-Reactive ProteinOligosaccharides

Autor:innen und Institutionen

  • Department of Clinical Sciences, Lund University, Malmö, Sweden; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.
  • Department of Medicine and Surgery, LUM University, Casamassima, Italy; Gastrointestinal Genetics Lab, CIC bioGUNE - BRTA, Derio, Spain; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.
  • Department of Clinical Sciences, Lund University, Malmö, Sweden; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden. Electronic address: bodil.ohlsson@med.lu.se.

Zitieren

APA

Roth, B., D'Amato, M., & Ohlsson, B. (2026). Improved lipid and glycemic profile and vitamin D levels after a dietary intervention with SSRD and low FODMAP in IBS patients: A randomized controlled trial. Nutrition. https://doi.org/10.1016/j.nut.2025.112964

Vancouver

Roth B, D'Amato M, Ohlsson B. Improved lipid and glycemic profile and vitamin D levels after a dietary intervention with SSRD and low FODMAP in IBS patients: A randomized controlled trial. Nutrition. 2026. doi:10.1016/j.nut.2025.112964

BibTeX
@article{Roth2026,
  author = {Roth, Bodil and D'Amato, Mauro and Ohlsson, Bodil},
  title = {Improved lipid and glycemic profile and vitamin D levels after a dietary intervention with SSRD and low FODMAP in IBS patients: A randomized controlled trial},
  journal = {Nutrition},
  year = {2026},
  doi = {10.1016/j.nut.2025.112964}
}
Kostenlos starten →